Login / Signup

Olfactory threshold predicts treatment response in relapsing multiple sclerosis.

Gabriel BstehHarald HegenKlaus BerekPatrick AltmannMichael AuerFranziska Di PauliLukas HaiderFritz LeutmezerPaulus Stefan RommerLisa-Maria WalchhoferSebastian WurthAnne ZinganellFlorian DeisenhammerThomas Berger
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
OT is an independent predictor of freedom of disease activity upon DMT initiation within 5 years and may be a useful biomarker of treatment response.
Keyphrases
  • disease activity
  • multiple sclerosis
  • systemic lupus erythematosus
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • ankylosing spondylitis
  • juvenile idiopathic arthritis
  • white matter